Wave Life Sciences (WVE) Accounts Payables (2014 - 2026)
Wave Life Sciences posted quarterly Accounts Payables of $19.1 million for Q1 2026, up 32.78% year-on-year from $14.4 million in Q1 2025, and up 21.43% on a QoQ basis from $15.7 million in Q4 2025.
Wave Life Sciences (WVE) has 13 years of Accounts Payables data on file, last reported at $19.1 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 32.78% year-over-year to $19.1 million; the trailing twelve-month figure through Mar 2026 stood at $19.1 million (up 32.78% YoY), and the FY2025 full-year result was $15.7 million, down 3.46% from the prior year.
- Accounts Payables for Q1 2026 stood at $19.1 million, up from $15.7 million in the prior quarter.
- Across five years, Accounts Payables topped out at $19.1 million in Q1 2026 and bottomed at $9.9 million in Q1 2022.
- The 5-year median for Accounts Payables is $14.4 million (2025), against an average of $14.2 million.
- Peak annual rise in Accounts Payables reached 132.32% in 2022, while the deepest fall reached 26.57% in 2022.
- A 5-year view of Accounts Payables shows it stood at $16.9 million in 2022, then fell by 24.1% to $12.8 million in 2023, then climbed by 26.66% to $16.3 million in 2024, then slipped by 3.46% to $15.7 million in 2025, then increased by 21.43% to $19.1 million in 2026.
- The last three Accounts Payables figures came in at $19.1 million (Q1 2026), $15.7 million (Q4 2025), and $14.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | 19.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.06 Mn |
| Dec 31, 2025 | 15.70 Mn |
| Sep 30, 2025 | 14.49 Mn |
| Jun 30, 2025 | 14.66 Mn |
| Mar 31, 2025 | 14.36 Mn |
| Dec 31, 2024 | 16.26 Mn |
| Sep 30, 2024 | 12.78 Mn |
| Jun 30, 2024 | 18.15 Mn |
| Mar 31, 2024 | 11.73 Mn |
| Dec 31, 2023 | 12.84 Mn |
| Sep 30, 2023 | 12.61 Mn |
| Jun 30, 2023 | 12.38 Mn |
| Mar 31, 2023 | 11.91 Mn |
| Dec 31, 2022 | 16.92 Mn |
| Sep 30, 2022 | 15.93 Mn |
| Jun 30, 2022 | 11.17 Mn |
| Mar 31, 2022 | 9.85 Mn |
| Dec 31, 2021 | 7.28 Mn |
| Sep 30, 2021 | 7.44 Mn |
| Jun 30, 2021 | 8.66 Mn |
| Mar 31, 2021 | 13.42 Mn |
| Dec 31, 2020 | 13.80 Mn |
| Sep 30, 2020 | 9.70 Mn |
| Jun 30, 2020 | 13.91 Mn |
| Mar 31, 2020 | 16.49 Mn |
| Dec 31, 2019 | 9.07 Mn |
| Sep 30, 2019 | 20.22 Mn |
| Jun 30, 2019 | 11.46 Mn |
| Mar 31, 2019 | 14.58 Mn |
| Dec 31, 2018 | 13.09 Mn |
| Sep 30, 2018 | 11.96 Mn |
| Jun 30, 2018 | 7.15 Mn |
| Mar 31, 2018 | 8.01 Mn |
| Dec 31, 2017 | 7.60 Mn |
| Sep 30, 2017 | 4.71 Mn |
| Jun 30, 2017 | 7.98 Mn |
| Mar 31, 2017 | 7.40 Mn |
| Dec 31, 2016 | 4.94 Mn |
| Sep 30, 2016 | 3.83 Mn |
| Jun 30, 2016 | 3.90 Mn |
| Mar 31, 2016 | 2.44 Mn |
| Dec 31, 2015 | 2.81 Mn |
| Sep 30, 2015 | 2.88 Mn |
| Dec 31, 2014 | 125,000.00 |